CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 90 filers reported holding CUREVAC N V in Q1 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,481 | -46.0% | 11,637 | -17.7% | 0.00% | – |
| Q2 2023 | $147,307 | -86.5% | 14,137 | -91.0% | 0.00% | – |
| Q1 2023 | $1,090,136 | +203.9% | 156,404 | +162.9% | 0.00% | – |
| Q4 2022 | $358,706 | +303.0% | 59,487 | +425.4% | 0.00% | – |
| Q3 2022 | $89,000 | -93.0% | 11,323 | -87.9% | 0.00% | – |
| Q2 2022 | $1,278,000 | +119.6% | 93,874 | +216.4% | 0.00% | – |
| Q1 2022 | $582,000 | -76.7% | 29,669 | -59.3% | 0.00% | – |
| Q4 2021 | $2,501,000 | +117.9% | 72,885 | +246.6% | 0.00% | – |
| Q3 2021 | $1,148,000 | -71.9% | 21,029 | -62.2% | 0.00% | – |
| Q2 2021 | $4,088,000 | +182.3% | 55,639 | +251.4% | 0.00% | – |
| Q1 2021 | $1,448,000 | -33.9% | 15,835 | -41.4% | 0.00% | – |
| Q4 2020 | $2,191,000 | +239.2% | 27,031 | +94.7% | 0.00% | – |
| Q3 2020 | $646,000 | – | 13,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |